Michael G. Kauffman

2020

In 2020, Michael G. Kauffman earned a total compensation of $3.9M as Chief Executive Officer at Karyopharm Therapeutics, a 22% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$348,750
Option Awards$1,920,899
Salary$625,624
Stock Awards$1,029,886
Other$11,880
Total$3,937,039

Kauffman received $1.9M in option awards, accounting for 49% of the total pay in 2020.

Kauffman also received $348.8K in non-equity incentive plan, $625.6K in salary, $1M in stock awards and $11.9K in other compensation.

Rankings

In 2020, Michael G. Kauffman's compensation ranked 2,897th out of 13,090 executives tracked by ExecPay. In other words, Kauffman earned more than 77.9% of executives.

ClassificationRankingPercentile
All
2,897
out of 13,090
78th
Division
Manufacturing
1,117
out of 5,618
80th
Major group
Chemicals And Allied Products
414
out of 2,251
82nd
Industry group
Drugs
358
out of 1,951
82nd
Industry
Pharmaceutical Preparations
263
out of 1,456
82nd
Source: SEC filing on April 7, 2021.

Kauffman's colleagues

We found two more compensation records of executives who worked with Michael G. Kauffman at Karyopharm Therapeutics in 2020.

2020

Sharon Shacham

Karyopharm Therapeutics

Chief Scientific Officer

2020

Michael Mason

Karyopharm Therapeutics

Chief Financial Officer

News

You may also like